SCHEMBL5852564

SCHEMBL5852564

Cc1ccc(S(=O)(=O)N(C(=O)[C@@H]2CCCN2)[C@@](C)(Cc2ccc(OC(=O)N3CCN(C)CC3)cc2)C(=O)O)cc1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 5/20 0.38
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850848 0.92 L3MBTL1 (0.36) NPY2RALDH1A1L3MBTL1NPSR1TP53
SCHEMBL5852560 0.92 CYP2C9 (0.45) NPY2RALDH1A1L3MBTL1HPGDMEN1
SCHEMBL5850597 0.88 CYP2D6 (0.36)
SCHEMBL5850585 0.86 PTGES (0.36) ALDH1A1KMT2A
SCHEMBL5850647 0.84 CYP1A2 (0.43) NPY2RALDH1A1L3MBTL1NPSR1TP53
SCHEMBL5850625 0.83 PTGES (0.34) NPY2RALDH1A1TP53
SCHEMBL5851162 0.82 CYP2C9 (0.41) NPY2RALDH1A1L3MBTL1NPSR1TP53
SCHEMBL5850810 0.80 DPP4 (0.35) ALDH1A1L3MBTL1NPSR1TP53ALOX15
SCHEMBL3850683 0.79 HTR2C (0.36) NPY2RMEN1KMT2ACYP1A2CYP2C9
SCHEMBL5850731 0.79 TAS2R14 (0.38) ALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US claimed
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed